Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Antibody for resisting to glucagon receptor and use thereof

A glucagon, antibody technology, applied in the direction of antibody, anti-receptor/cell surface antigen/cell surface determinant immunoglobulin, anti-animal/human immunoglobulin, etc., to reduce the level of intracellular cAMP

Inactive Publication Date: 2014-12-24
GMAX BIOPHARM
View PDF11 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, in some type 1 or type 2 diabetes, absolute or relative high glucagon results in hyperglycemia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antibody for resisting to glucagon receptor and use thereof
  • Antibody for resisting to glucagon receptor and use thereof
  • Antibody for resisting to glucagon receptor and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0055] The technical solutions of the present invention will be further specifically described below through specific embodiments and in conjunction with the accompanying drawings.

[0056] In the present invention, unless otherwise specified, the raw materials and equipment used can be purchased from the market or commonly used in this field. The methods in the following examples, unless otherwise specified, are conventional methods in the art.

[0057] The present invention relates to antibodies such as antibodies that specifically bind to the human glucagon receptor (GCGR). These include antigen binding proteins that inhibit or block the binding of glucagon to human GCGR and reduce glucagon signaling through the receptor. In one embodiment there is provided a murine antibody that lowers blood sugar in an animal, including an antagonist antibody.

[0058] The present invention further provides antibody-related compositions, kits and methods that can specifically bind to th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an antibody for resisting to a glucagon receptor and use thereof, and more particularly relates to a monoclonal antibody capable of being specifically combined with a human glucagon receptor as well as use of the antibody for treating or preventing Diabetes mellitus II and related diseases in mammals. The invention provides the novel antibody for resisting to a glucagon receptor capable of being specifically combined with a glucagon receptor. The cAMP level in a cell is reduced by means of inhibiting combination of glucagon and the receptor.

Description

technical field [0001] The present invention relates to an antibody, in particular to an anti-glucagon receptor antibody and its application. Background technique [0002] Human glucagon is an important hormone that acts together with insulin and participates in the regulation of glucose content in human blood. Glucagon and insulin are both peptide hormones. Glucagon is produced in the alpha islet cells of the pancreas and insulin is produced in the beta islet cells. When blood sugar levels fall, glucagon mainly releases glucose by stimulating some target cells (mainly liver cells). Glucagon and insulin regulate blood sugar in opposite ways. Insulin stimulates cells to take up and store glucose when blood sugar rises , lower blood sugar concentration. [0003] Natural human glucagon is composed of 29 amino acid residues: [0004] NH 2 -His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp -Leu-Met-Asn-Thr-COOH [0005] Glu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/28C12N15/13C12N15/63A61K39/395A61P3/10
Inventor 张成汪笑峰景书谦
Owner GMAX BIOPHARM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com